Figure 2
Dose-response curves of subgroups. Note the concordance in decrement rates in groups S2, S22 and S212, who received 200 mg
l-selemethionine/day, and the decreased response in group S222. Rising serum concentrations of TPOAb in group S21 clearly confirms
the ineffectiveness of 100 mg l-selemethionine/day.